Thyssenkrupp Nucera Management AG announced key leadership changes aimed at strengthening its position in the dynamic hydrogen market. The Supervisory Board has unanimously resolved to extend the contract of Dr. Werner Ponikwar as CEO for five additional years, securing his leadership until July 2030.

Under Dr. Ponikwar's tenure, thyssenkrupp Nucera achieved significant milestones, including its IPO in 2023 and notable advancements in hydrogen technology. Dr. Volkmar Dinstuhl, Chairman of the Supervisory Board, commended Ponikwar's strategic vision, emphasizing his pivotal role in the company's growth and innovation.

Additionally, Dr. Stefan Hahn will assume the role of CFO effective March 1, 2025, succeeding Dr. Arno Pfannschmidt, who is set to retire. Dr. Hahn brings extensive financial expertise from his tenure at thyssenkrupp AG, where he held senior positions in Finance & Controlling, most recently as interim CFO for the Business Unit Polysius.

Meanwhile, Fulvio Federico, the current CTO, has announced his decision to step down from the Management Board for personal reasons. The company has initiated an orderly succession process to ensure a smooth transition, with Federico advising during the interim period.

"Stefan Hahn is an accomplished financial expert with an impressive track record. We are confident in his ability to contribute to thyssenkrupp Nucera's continued success," said Dr. Dinstuhl. He also expressed gratitude to both Dr. Pfannschmidt and Fulvio Federico for their leadership, which has been instrumental in the company's transformation into a standalone, publicly listed entity.

Source: thyssenkrupp-nucera.com